K. Hou‐Jensen

发表

Primary cutaneous B‐cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases

P. Guldberg, K. Grønbæk, J. Zeuthen, 2000, The British journal of dermatology.

An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.

D. Mason, J. Skinner, K. Pulford, 1985, Journal of clinical pathology.

Gene in Lymphoid Malignancies MMAC1/PTEN Alterations of the

P. Guldberg, K. Grønbæk, J. Zeuthen, 2011 .

Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group.

D. Ruiter, E. Bröcker, R. MacKie, 1993, European journal of cancer.

Alterations of the MMAC1/PTEN gene in lymphoid malignancies.

P. Guldberg, J. Zeuthen, K. Hou‐Jensen, 1998, Blood.

In situ immunological characterization of Langerhans cells with monoclonal antibodies: Comparison with other dendritic cells in skin and lymph nodes

H. Stein, D. Mason, T. Plesner, 2004, Virchows Archiv A.

The presence of dysplastic nevus remnants in malignant melanomas. A population-based study of 551 malignant melanomas.

K. Hou‐Jensen, K. Drzewiecki, N. Hastrup, 1991, The American Journal of dermatopathology.

Acute non‐lymphocytic leukemia in patients with ovarian carcinoma following long‐term treatment with treosulfan (=dihydroxybusulfan)

N. Nissen, C. Rose, J. Pedersen‐Bjergaard, 1980, Cancer.

DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course

I. Christensen, J. Larsen, K. Hou‐Jensen, 1983, Virchows Archiv. B, Cell pathology including molecular pathology.

Factor VIII related antigen as an endothelial cell marker in benign and malignant diseases

M. Sehested, K. Hou‐Jensen, Hou-Jensen Klaus, 2004, Virchows Archiv A.

Sunscreens for delay of ultraviolet induction of skin tumors.

H. Wulf, T. Poulsen, K. Hou‐Jensen, 1982, Journal of the American Academy of Dermatology.

High activity of mitoxantrone in previously untreated low-grade lymphomas

N. Nissen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 2004, Cancer Chemotherapy and Pharmacology.

Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer.

K. Hou‐Jensen, A. Osterlind, O. MÃ¸ller Jensen, 1988, British Journal of Cancer.

Gastric cancer incidence in the Faroe Islands.

K. Hou‐Jensen, O. M. Jensen, J. Poulsen, 1984, British Journal of Cancer.

Apoptosis‐related genes and proteins in Hodgkin's disease

P. Guldberg, T. Nedergaard, K. Hou‐Jensen, 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders

S. Vorstrup, A. Wiik, C. Geisler, 1999, Journal of internal medicine.

P53 protein expression in Hodgkin's disease

K. Hou‐Jensen, E. Ralfkiaer, A. Lauritzen, 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

The ultrastructure of gonadoblastoma and dysgerminoma

R. Kempson, K. Hou‐Jensen, 1974 .

Expression of gp100, MART‐1, tyrosinase, and S100 in paraffin‐embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group

A. Eggermont, E. Bröcker, K. Hou‐Jensen, 2001, The Journal of pathology.

Normal and neoplastic Langerhans cells: phenotypic comparison with other types of macrophages.

H. Stein, D. Mason, K. Hou‐Jensen, 1985, Advances in experimental medicine and biology.

Benign and malignant lymphocytic skin infiltrates: immunological patterns recognized by immunohistochemical staining with monoclonal antibodies.

H. Stein, D. Mason, K. Thomsen, 1985, Advances in experimental medicine and biology.

Metastases in dermatological patients with squamous cell carcinoma.

K. Hou‐Jensen, F. Reymann, R. Møller, 1979, Archives of dermatology.

Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.

N. Nissen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 1988, The New England journal of medicine.

p53 protein expression in cutaneous T‐cell lymphomas

K. Hou‐Jensen, E. Ralfkiaer, G. Vejlsgaard, 1995, The British journal of dermatology.

Studies on ultrastructure of Ewing's sarcoma of bone

K. Hou‐Jensen, L. Dmochowski, E. Priori, 1972, Cancer.

Organisation of the Danish adjuvant trials in breast cancer.

M. Ro̸rth, H. Mouridsen, H. Johansen, 1981, Danish medical bulletin.

277-286 JINT443f

S. Vorstrup, A. Wiik, C. Geisler, 1999 .

Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses.

H. Stein, D. Mason, K. Thomsen, 1985, American journal of clinical pathology.

Cutaneous lymphocytomas: clinical and histological aspects.

K. Thomsen, K. Hou‐Jensen, G. L. Wantzin, 1982, Acta dermato-venereologica.

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.

S. Larsen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 1993, Leukemia.

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Leukemia.

Acute nonlymphocytic leukemia following treatment of testicular cancer and gastric cancer with combination chemotherapy not including alkylating agents: Report of two cases

M. Ro̸rth, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 1985, American journal of hematology.

Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study.

N. E. Hansen, G. Delsol, K. Hou‐Jensen, 1994, American journal of clinical pathology.

Immunohistochemical identification of lymphocyte subsets and accessory cells in human hyperplastic lymph nodes. The functional significance of the compartmentalization of lymphoid tissue.

N. Nissen, T. Plesner, K. Thomsen, 2009, Scandinavian journal of haematology.

Proliferating histiocytic lesion (Histiocytosis‐X?). Association of an extensive mediastinal and retroperitoneal sclerosing lesion with Gagel's granuloma of the posterior lobe of the pituitary

M. Hendrickson, K. Hou‐Jensen, D. Rawlinson, 1973, Cancer.

Malignant haemangiopericytomas and haemangioendotheliosarcomas: an immunohistochemical study

H. Mouridsen, H. Johansen, K. Hou‐Jensen, 1988, Histopathology.

Clinical features of malignant haemangiopericytomas and haemangioendotheliosarcomas.

H. Mouridsen, K. Hou‐Jensen, S. Daugaard, 1988, Acta oncologica.

A new embedding material in frozen tissue techniques.

K. Hou‐Jensen, 1966, Acta pathologica et microbiologica Scandinavica.

Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients.

K. Hou‐Jensen, J. Geiger, J. Serup, 1991, Journal of the American Academy of Dermatology.

Bcl‐2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas

G. Jacobsen, K. Hou‐Jensen, K. Rossen, 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Squamous cell carcinoma of the skin and internal malignant neoplasms.

K. Hou‐Jensen, A. Nielsen, F. Reymann, 1979, Archives of dermatology.

Metastatic cancer in guinea pigs irradiated with grenz rays.

H. Wulf, K. Hou‐Jensen, 1979, Archives of dermatology.

[Significant prognostic factors for recurrence-free survival after surgical treatment of head-neck melanoma].

K. Hou‐Jensen, A. Andersson, K. Søndergaard, 1993, Ugeskrift for laeger.

Skin melanoma of the head and neck: Prognostic factors and recurrence‐free survival in 512 patients

K. Hou‐Jensen, K. Drzewiecki, A. Andersson, 2010, Cancer.

Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.

G. Jacobsen, K. Hou‐Jensen, K. Rossen, 1995, Acta dermato-venereologica.

Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas

D. Mason, K. Gatter, K. Hou‐Jensen, 2004, Virchows Archiv A.

The ultrastructure of gonadoblastoma and dysgerminoma.

R. Kempson, K. Hou‐Jensen, 1974, Human pathology.

The Danish case‐control study of cutaneous malignant melanoma. I. Importance of host factors

M. Tucker, K. Hou‐Jensen, G. Engholm, 1988, International journal of cancer.

Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas

G. Jacobsen, K. Hou‐Jensen, K. Rossen, 1997, The British journal of dermatology.

Lymphomatoid papulosis: a follow-up study.

K. Thomsen, K. Hou‐Jensen, G. Lange-Wantzin, 1984, Acta dermato-venereologica.

[Pseudolymphoma and ventricular maltoma in patients with chronic gastritis, ulcer and Helicobacter pylori infection].

A. Wiik, K. Hou‐Jensen, S. Molander, 2000, Ugeskrift for laeger.

Metastatic melanoma with balloon cell changes: an electron microscopic study.

K. Hou‐Jensen, K. Søndergaard, A. Henschel, 1980, Ultrastructural pathology.

Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.

P. Guldberg, J. Zeuthen, K. Hou‐Jensen, 2000, The Journal of investigative dermatology.

Immunoperoxidase staining for carcinoembryonic antigen in small cell carcinoma of the lung.

F. Hirsch, M. Sehested, K. Hou‐Jensen, 1981, European journal of cancer & clinical oncology.

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Blood.

In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.

P. Andersen, C. Geisler, J. Larsen, 1997, Leukemia research.

Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients

N. Nissen, J. Pedersen‐Bjergaard, K. Hou‐Jensen, 1984, Cancer.

Hormone-dependent uterine sarcomas in GR mice.

P. Briand, C. Rose, K. Hou‐Jensen, 1981, European journal of cancer.

Hormonal induction of uterine sarcomas in GR mice not dependent on mammary tumor virus genes or uterine trauma.

P. Briand, K. Hou‐Jensen, R. van Nie, 1985, European journal of cancer & clinical oncology.

Histopathological characteristics and oestrogen receptor content in primary breast carcinoma

B. Rasmussen, C. Rose, K. Hou‐Jensen, 2004, Virchows Archiv A.

Comparison of the immunocytochemical assay (ER-ICA) and the biochemical assay for estrogen receptor in human breast cancer cell lines.

P. Briand, A. Lykkesfeldt, K. Hou‐Jensen, 1987, European journal of cancer & clinical oncology.

Bone Marrow Involvement in Mycosis Fungoides Demonstrated by Needle Biopsy

K. Thomsen, K. Hou‐Jensen, A. Worm, 1978, Journal of cutaneous pathology.

Preferential usage of T‐cell receptor αβ variable regions among tumor‐infiltrating lymphocytes in primary human malignant melanomas

J. Schøller, J. Zeuthen, K. Hou‐Jensen, 2007 .

On the Occurrence of Post Nasal Space Tumours in Kenya

Copenhagen, K. Hou‐Jensen, Kenya, 1964, British Journal of Cancer.

Comparison of the working formulation of non‐Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution

P. Hougaard, N. Nissen, K. Hou‐Jensen, 1985, Cancer.

Argyrophilic cells in 202 human mucinous breast carcinomas. Relation to histopathologic and clinical factors.

B. Rasmussen, C. Rose, K. Hou‐Jensen, 1985, American journal of clinical pathology.

Malignant melanoma of the skin in children (0 to 14 years of age) in Denmark, 1943-1982.

K. Hou‐Jensen, K. Drzewiecki, A. Osterlind, 1990, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

Cytoplasmic inclusions in lymphocytes of chronic lymphocytic leukaemia

T. Plesner, K. Hou‐Jensen, E. Ralfkiær, 1982, Virchows Archiv A.

The bone‐marrow infiltration pattern in B‐cell chronic lymphocytic leukemia is not an important prognostic factor

P. Andersen, C. Geisler, J. Larsen, 1996, European journal of haematology.

The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia

S. Larsen, C. Geisler, K. Hou‐Jensen, 1986, British journal of haematology.

Nuclear clefts in chronic lymphocytic leukaemia. A light microscopic and ultrastructural study of a new prognostic parameter.

C. Geisler, K. Hou‐Jensen, E. Ralfkiaer, 2009, Scandinavian journal of haematology.

Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients.

J. Zeuthen, K. Hou‐Jensen, A. Birck, 1999, Melanoma research.

Selection of High Risk Groups Among Prognostically Favorable Patients with Breast Cancer: An Analysis of the Value of Prospective Grading of Tumor Anaplasia in 1,048 Patients

H. Johansen, E. Henriksen, K. Hou‐Jensen, 1981, Annals of surgery.

Partial regression in thin primary cutaneous malignant melanomas clinical stage I

K. Hou‐Jensen, Knud Søndergaard, Klaus Hou-Jensen, 1985, Virchows Archiv A.

Observer variation in histological classification of cutaneous malignant melanoma.

P. Andersen, K. Hou‐Jensen, N. K. Jensen, 1995, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[Histology and prognosis in cutaneous malignant melanoma].

K. Hou‐Jensen, K. Søndergaard, 1977, Ugeskrift for laeger.

DEGOS' DISEASE TREATED WITH PLATELET-SUPPRESSIVE DRUGS

K. Thomsen, K. Hou‐Jensen, D. Stahl, 1977, The Lancet.

A simplified working formulation of non‐Hodgkin's lymphomas based on quantifiable histologic criteria

N. Nissen, K. Hou‐Jensen, J. Ersbøll, 1989, Cancer.

Comparison of the Working Formulation of non-Hodgkin’s lymphoma with the Rappaport, the Kiel, and the Lukes-Collins Classifications. Correlations and prognostic value

P. Hougaard, N. Nissen, K. Hou‐Jensen, 1985 .

Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease

L. Specht, N. Nissen, K. Hou‐Jensen, 1990 .

Cytoplasmic Inclusions in Lymphocytes of Chronic

T. Plesner, K. Hou‐Jensen, C. Geisler, 1982 .

Malignant atrophic papulosis: treatment with aspirin and dipyridamole.

K. Thomsen, K. Hou‐Jensen, D. Stahl, 1978, Archives of dermatology.

The development of a Ki-1-positive large cell non-Hodgkin's lymphoma in pagetoid reticulosis.

K. Thomsen, K. Hou‐Jensen, E. Ralfkiaer, 1989, Acta dermato-venereologica.

Lactic acid dehydrogenase isoenzymes in human melanomas.

K. Hou‐Jensen, 2009, Acta pathologica et microbiologica Scandinavica.

Leiomyosarcoma of the urinary bladder after cyclophosphamide.

J. Pedersen‐Bjergaard, K. Hou‐Jensen, M. Pedersen, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histochemical demonstration of some hydrolytic enzymes in human skin wounds. Their applicability as vital reactions in medico-legal practice.

K. Hou‐Jensen, 1968, Journal of forensic medicine.

Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark.

L. Specht, N. Nissen, K. Hou‐Jensen, 1991, Danish medical bulletin.

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

J. Zeuthen, K. Hou‐Jensen, P. thor Straten, 1994, International journal of cancer.

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.

J. Schøller, J. Zeuthen, K. Hou‐Jensen, 1994, International journal of cancer.

Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease

L. Specht, N. Nissen, K. Hou‐Jensen, 1990, Cancer.

Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi

K. Hou‐Jensen, N. Hastrup, 1993, Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS).

DIFFERENTIATION OF LARGE VACUOLATED NEOPLASTIC CELLS IN EPIDERMIS BY MEANS OF PAS‐STAINING

K. Hou‐Jensen, 2009 .